MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-WB-10-0023442
Survi Pharmaceutical Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹4.04 Lakh
▼ 29% YoY
Net loss · FY 2024
₹6,857
Net margin -1.7%
EBITDA · FY 2024
₹20,694
EBITDA margin 5.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
11 yrs
Est. 2015
Directors on board
2
As per MCA filings
About Survi Pharmaceutical Private Limited
Data last updated:
Survi Pharmaceutical Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 March 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U51909WB2015PTC205716. Its GSTIN is 19AAVCS5831K1ZI (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tukeshwar Dutta Sinha and Sarita Dutta Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 243/1 Sahid Hemanta Kumar Basu Sarani, Kolkata, West Bengal, India – 700074.
As per the financials filed for FY 2024, the company reported a revenue of ₹4.04 Lakh, a decline of 29% compared to the previous year. For the same year it recorded a net loss of ₹6,857 (net margin -1.7%) and EBITDA of ₹20,694 (EBITDA margin 5.1%). Revenue has grown at a compounded annual rate (CAGR) of 27% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Survi Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0023442). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website survipharmaceutical.com.
Company details
CIN U51909WB2015PTC205716
Registration Number 205716
Incorporation Date 20 March 2015
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-WB-10-0023442
Recognitions & Rankings of Survi Pharmaceutical
Contact details
Survi Pharmaceutical Private Limited's registered office is in Kolkata, West Bengal. Its website is survipharmaceutical.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address243/1 Sahid Hemanta Kumar Basu Sarani, Kolkata, West Bengal, India – 700074
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Survi Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Survi Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Survi Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Survi Pharmaceutical Private Limited, buy the company report.
Financials of Survi Pharmaceutical Private Limited
FY 2025 filings availableSurvi Pharmaceutical Private Limited reported revenue of ₹4.04 Lakh (down 29% YoY) for FY 2024.
Revenue · FY 2024
₹4.04 Lakh ▼ 29%
Net loss · FY 2024
₹6,857 margin -1.7%
EBITDA · FY 2024
₹20,694 margin 5.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 29%
3 years · compounded
▲ 27%
5 years · compounded
▲ 4%
EBITDA CAGR growth
3 years · compounded
▲ 78%
5 years · compounded
▼ 27%
Revenue fell 29% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹20,694 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹6,857 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.1% | ||||
| Net Profit Margin | -1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Survi Pharmaceutical Private Limited, buy the company report.
Board of directors of Survi Pharmaceutical Private Limited
Survi Pharmaceutical has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tukeshwar Dutta Sinha | Director | 20 Mar 2015 | 11 Years 7 Months | Current |
| Sarita Dutta Sinha | Director | 20 Mar 2015 | 11 Years 7 Months | Current |
Peer comparison
Survi Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cyla Healthcare Private Limited | ₹4.05 Lakh (FY 2025) | New Delhi, Delhi, India | ||||
| Saiman Aromatics Private Limited | ₹4.04 Lakh (FY 2024) | -94.0% | Bareilly, Uttar Pradesh, India | |||
| Murasa Pharmaceuticals Private Limited | ₹4.04 Lakh (FY 2024) | 91.0% | Mumbai, Maharashtra, India | |||
| Perfect Fit Fashions Private Limited | ₹4.04 Lakh (FY 2023) | 12.0% | Kozhikode, Kerala, India | |||
| Precure Pharma Private Limited | ₹4.04 Lakh (FY 2025) | -37.0% | Lucknow, Uttar Pradesh, India | |||
| Survi Pharmaceutical Private Limitedthis company | ₹4.04 Lakh (FY 2024) | -₹6,857 | -1.7% | -29.0% | Kolkata, West Bengal, India | |
| MSPR Insurance Marketing Private Limited | ₹4.04 Lakh (FY 2025) | -72.0% | Hyderabad, Telangana, India | |||
| Relyone Corporates Private Limited | ₹4.04 Lakh (FY 2025) | 1128.0% | Thane, Maharashtra, India | |||
| Franz & Filo Bakers Private Limited | ₹4.04 Lakh (FY 2024) | 94.0% | Pune, Maharashtra, India | |||
| Brovo Surfaces Private Limited | ₹4.04 Lakh (FY 2020) | -95.0% | Ahmedabad, Gujarat, India | |||
| Henry Commercial Private Limited | ₹4.04 Lakh (FY 2018) | -97.0% | Bikaner, Rajasthan, India |
To see the full peer comparison of Survi Pharmaceutical Private Limited, buy the company report.
Auditor
Survi Pharmaceutical Private Limited is audited by D K MALOO & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D K MALOO & ASSOCIATES | FY 2017 | 320277E |
Shareholding
The shareholding of Survi Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Survi Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 31 Mar 2025 | 101085268 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Survi Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Survi Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Survi Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAVCS5831K1ZI | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Survi Pharmaceutical Private Limited, buy the company report.
Recent activity
Survi Pharmaceutical Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Sarita Dutta Sinha was appointed as Director on 20 Mar 2015.
AGM
Survi Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Survi Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Charges
A charge with State Bank Of India amounted to Rs. 10.00 Lakh with Charge ID 101085268 was registered on 31 Mar 2025.
Appointed
Sarita Dutta Sinha was appointed as Director.
Appointed
Tukeshwar Dutta Sinha was appointed as Director.
Incorporation
20 Mar 2015
Survi Pharmaceutical Private Limited was registered on 20 Mar 2015 with Roc Kolkata I & aged 11 years 7 months as per MCA records.
Frequently asked questions
Survi Pharmaceutical is an active private limited company based in Kolkata, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 March 2015 (11+ years old) and is registered under CIN U51909WB2015PTC205716.
Survi Pharmaceutical has 2 current directors:
- Tukeshwar Dutta Sinha - Director
- Sarita Dutta Sinha - Director
The latest financial statements of Survi Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Survi Pharmaceutical is 19AAVCS5831K1ZI, registered in West Bengal.
The CIN (Corporate Identification Number) of Survi Pharmaceutical is U51909WB2015PTC205716. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Survi Pharmaceutical was incorporated on 20 March 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Survi Pharmaceutical by revenue are Cyla Healthcare Private Limited, Saiman Aromatics Private Limited, Murasa Pharmaceuticals Private Limited, Perfect Fit Fashions Private Limited, Precure Pharma Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Sarita Dutta Sinha was appointed as Director on 20 Mar 2015. Tukeshwar Dutta Sinha was appointed as Director on 20 Mar 2015.
Yes, Survi Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-WB-10-0023442).
Survi Pharmaceutical can be reached through the website survipharmaceutical.com. Its registered office is in Kolkata, West Bengal, India.
The registered office of Survi Pharmaceutical is at 2431 Sahid Hemanta Kumar Basu Sarani, Kolkata, West Bengal, India – 700074.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages